Aprea Therapeutics, Inc.: accounts_payable
| Value | {"amount": 713668, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-12-31) |
| Status | current |
| Entity | Aprea Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:02:26.698441+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/629f42a0-44b8-4823-8151-829bcf01a41c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-26-028068Retrieved: 2026-08-19T18:02:26.698441+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001781983/accounts-payable/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/629f42a0-44b8-4823-8151-829bcf01a41c
History
- no predecessors — first report